跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方氨酚烷胺胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Capsules
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Capsules
通化兴华药业有限责任公司
🇨🇳 National Medical Products Administration
Approval Date
Feb 13, 2020
Approval ID
7LeafeXaMpA
Company
通化兴华药业有限责任公司
Type
化学药品
Approval Details
Approval Id
7LeafeXaMpA
Approval Number
国药准字H22025439
Generic Name
复方氨酚烷胺胶囊
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
复方
Reg Date
2020-02-13
Company Name
通化兴华药业有限责任公司
Production Company Name
通化兴华药业有限责任公司
Production Company Address
通化市金龙路158号
Company Detail Path
/organization/tong-hua-xing-hua-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path
/organization/tong-hua-xing-hua-yao-ye-you-xian-ze-ren-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 13, 2020
Approval ID
7LeafeXaMpA
Type
化学药品
Back to NMPA Approvals